Biopôle is a science park of 80,000 square metres destined to host companies whose main activity is in the life sciences field. While it is open to all therapeutic areas, the main focus is on developing innovative solutions in the fields of oncology, immunology and personalised medicine. Biopôle offers space for industrial research and development or administrative use.
The Biopôle is owned at 98% by the Canton of Vaud. It is located in Épalinges, to the north of Lausanne and is the first of its kind in French-speaking part of Switzerland. The Biopôle site is located at the intersection of the large Lausanne campus, complementing the University Hospital of Lausanne (CHUV), the Swiss Federal Institute of Technology in Lausanne (EPFL), the University of Lausanne and the major industrial concerns.
Biopole SA was established in 2004 as a limited company by the public authorities of the Canton of Vaud, who are the major shareholders. In November 2005, the company presented its shareholders with the development plan of the site, together with its business plan. The aims of the company are to develop by the year 2015 more than 60,000 square metres of rental space, which would allow over 2,000 people to come and work on the site. In autumn 2007 work began on the first Biopôle building, and at the end of 2008 the first tenants moved in.
The park is composed of four zones:
As of February 2016 the site accounts: